$ANIX
Anixa Biosciences Inc

2024 Q3 Form 10-Q Financial Statement

#000149315224035335 Filed on September 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.667M
YoY Change -5.07%
% of Gross Profit
Research & Development $1.925M
YoY Change 76.93%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.925M
YoY Change 76.93%
Operating Profit -$3.592M
YoY Change 26.3%
Interest Expense $277.0K
YoY Change -6.42%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.315M
YoY Change 30.1%
Income Tax
% Of Pretax Income
Net Earnings -$3.277M
YoY Change 30.51%
Net Earnings / Revenue
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.10
COMMON SHARES
Basic Shares Outstanding 32.05K shares
Diluted Shares Outstanding 32.05K shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.75M
YoY Change -18.76%
Cash & Equivalents $1.225M
Short-Term Investments $19.52M
Other Short-Term Assets $1.515M
YoY Change 184.77%
Inventory
Prepaid Expenses
Receivables $410.0K
Other Receivables $0.00
Total Short-Term Assets $22.67M
YoY Change -14.13%
LONG-TERM ASSETS
Property, Plant & Equipment $238.0K
YoY Change 33.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $238.0K
YoY Change 33.71%
TOTAL ASSETS
Total Short-Term Assets $22.67M
Total Long-Term Assets $238.0K
Total Assets $22.91M
YoY Change -13.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $302.0K
YoY Change 221.28%
Accrued Expenses $1.678M
YoY Change -1.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.004M
YoY Change 7.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $213.0K
YoY Change 56.62%
Total Long-Term Liabilities $213.0K
YoY Change 56.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.004M
Total Long-Term Liabilities $213.0K
Total Liabilities $2.217M
YoY Change 11.24%
SHAREHOLDERS EQUITY
Retained Earnings -$237.9M
YoY Change 5.48%
Common Stock $321.0K
YoY Change 3.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.77M
YoY Change
Total Liabilities & Shareholders Equity $22.91M
YoY Change -13.81%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$3.277M
YoY Change 30.51%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.643M
YoY Change 82.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.724M
YoY Change -377.96%
Cash From Investing Activities $2.724M
YoY Change -377.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 149.0K
YoY Change 4866.67%
NET CHANGE
Cash From Operating Activities -2.643M
Cash From Investing Activities 2.724M
Cash From Financing Activities 149.0K
Net Change In Cash 230.0K
YoY Change -109.5%
FREE CASH FLOW
Cash From Operating Activities -$2.643M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Royalty Expense
RoyaltyExpense
usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
915000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
19520000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
22929000 usd
CY2024Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
410000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
270000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1515000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1242000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
25356000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
238000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
166000 usd
CY2024Q3 us-gaap Assets
Assets
22908000 usd
CY2023Q4 us-gaap Assets
Assets
25522000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1678000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1770000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2004000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2028000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
213000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
123000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2217000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2151000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
100
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
100
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
19860 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
19860 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32146460 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31145219 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31145219 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
321000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
311000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
259317000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
21771000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24337000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-1080000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-966000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23371000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22908000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25522000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
210000 usd
us-gaap Royalty Expense
RoyaltyExpense
161000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1925000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1088000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4920000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3154000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1667000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1756000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5748000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4855000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
3592000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
2844000 usd
us-gaap Costs And Expenses
CostsAndExpenses
10668000 usd
us-gaap Costs And Expenses
CostsAndExpenses
8170000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2844000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10668000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7960000 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
277000 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
296000 usd
us-gaap Interest Income Other
InterestIncomeOther
883000 usd
us-gaap Interest Income Other
InterestIncomeOther
751000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3315000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-2548000 usd
us-gaap Profit Loss
ProfitLoss
-9785000 usd
us-gaap Profit Loss
ProfitLoss
-7209000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-38000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-37000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-114000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-88000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32054 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32054 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30974 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30974 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31804 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30941 shares
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22581000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Entity Central Index Key
EntityCentralIndexKey
0000715446
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2024Q3 us-gaap Royalty Expense
RoyaltyExpense
usd
CY2023Q3 us-gaap Royalty Expense
RoyaltyExpense
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
ANIX Non Cash Investing Activity Operating Lease Rightofuse Asset
NonCashInvestingActivityOperatingLeaseRightofuseAsset
usd
ANIX Non Cash Investing Activity Operating Lease Liability
NonCashInvestingActivityOperatingLeaseLiability
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37492
dei Entity Registrant Name
EntityRegistrantName
ANIXA BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-2622630
dei Entity Address Address Line1
EntityAddressAddressLine1
3150 Almaden Expressway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 250
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95118
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
708-9808
dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
dei Trading Symbol
TradingSymbol
ANIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32179492 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.01
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1225000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
22670000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
302000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
206000 usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32146460 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
252222000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-237867000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-228196000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20691000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3592000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3277000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2511000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9671000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7121000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31804 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30941 shares
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1094000 usd
CY2024Q3 ANIX Adjustments To Additional Paid In Capital Options Issued
AdjustmentsToAdditionalPaidInCapitalOptionsIssued
23000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
45000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
194000 usd
CY2024Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
60000000 shares
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
159000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3315000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20691000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25913000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1153000 usd
CY2023Q3 ANIX Adjustments To Additional Paid In Capital Options Issued
AdjustmentsToAdditionalPaidInCapitalOptionsIssued
47000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-2548000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24585000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23371000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3440000 usd
ANIX Adjustments To Additional Paid In Capital Options Issued
AdjustmentsToAdditionalPaidInCapitalOptionsIssued
101000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
139000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2984000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
318000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
255000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7000 usd
us-gaap Profit Loss
ProfitLoss
-9785000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20691000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28200000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28200000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3265000 usd
ANIX Adjustments To Additional Paid In Capital Options Issued
AdjustmentsToAdditionalPaidInCapitalOptionsIssued
175000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
81000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
67000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000 usd
us-gaap Profit Loss
ProfitLoss
-7209000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24585000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24585000 usd
us-gaap Profit Loss
ProfitLoss
-9785000 usd
us-gaap Profit Loss
ProfitLoss
-7209000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3440000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3265000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
101000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
175000 usd
ANIX Common Stock Issued To Consultants
CommonStockIssuedToConsultants
255000 usd
ANIX Common Stock Issued To Consultants
CommonStockIssuedToConsultants
67000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
28000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
34000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
140000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
288000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
273000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
65000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
96000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-171000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-92000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-38000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-34000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6408000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4240000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
47307000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
27502000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
50716000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
22493000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3409000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5009000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
139000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2984000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
7000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
6000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
318000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
81000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3309000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
87000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
310000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9162000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
915000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12360000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1225000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3198000 usd
ANIX Non Cash Investing Activity Operating Lease Rightofuse Asset
NonCashInvestingActivityOperatingLeaseRightofuseAsset
-100000 usd
ANIX Non Cash Investing Activity Operating Lease Liability
NonCashInvestingActivityOperatingLeaseLiability
100000 usd
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
20745000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
23844000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
3099000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-966000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-114000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-1080000 usd
ANIX Revenue Recognition Percentage
RevenueRecognitionPercentage
1 pure
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
900000 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1114000 usd
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
626000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
626000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
152000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1678000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1770000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
11000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
56000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
63000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
65000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
66000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
63000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
324000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
87000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
237000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3315000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-2548000 usd
us-gaap Profit Loss
ProfitLoss
-9785000 usd
us-gaap Profit Loss
ProfitLoss
-7209000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3315000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-2548000 usd
us-gaap Profit Loss
ProfitLoss
-9785000 usd
us-gaap Profit Loss
ProfitLoss
-7209000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
3592000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
2844000 usd
us-gaap Costs And Expenses
CostsAndExpenses
10668000 usd
us-gaap Costs And Expenses
CostsAndExpenses
8170000 usd
CY2024Q3 ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-1179000 usd
CY2023Q3 ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-1217000 usd
ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-3699000 usd
ANIX Noncash Sharebased Compensation
NoncashSharebasedCompensation
-3507000 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2413000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1627000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6969000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4663000 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2413000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1627000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6969000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4663000 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2413000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1627000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6969000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4663000 usd
CY2024Q3 us-gaap Assets
Assets
22908000 usd
CY2023Q4 us-gaap Assets
Assets
25522000 usd
CY2024Q3 us-gaap Assets
Assets
22908000 usd
CY2023Q4 us-gaap Assets
Assets
25522000 usd

Files In Submission

Name View Source Status
0001493152-24-035335-index-headers.html Edgar Link pending
0001493152-24-035335-index.html Edgar Link pending
0001493152-24-035335.txt Edgar Link pending
0001493152-24-035335-xbrl.zip Edgar Link pending
anix-20240731.xsd Edgar Link pending
anix-20240731_cal.xml Edgar Link unprocessable
anix-20240731_def.xml Edgar Link unprocessable
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
anix-20240731_lab.xml Edgar Link unprocessable
anix-20240731_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending